Your browser doesn't support javascript.
loading
Impaired wound healing secondary to bevacizumab.
Ahn, Ji W; Shalabi, Doaa; Correa-Selm, Lilia M; Dasgeb, Bahar; Nikbakht, Neda; Cha, Jisun.
Afiliación
  • Ahn JW; Department of Dermatology, University of Michigan Hospitals, Ann Arbor, Michigan.
  • Shalabi D; Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Correa-Selm LM; Scully Welsh Cancer Center, Cleveland Clinic Indian River Hospital, Vero Beach, Florida.
  • Dasgeb B; Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Nikbakht N; Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Cha J; Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
Int Wound J ; 16(4): 1009-1012, 2019 Aug.
Article en En | MEDLINE | ID: mdl-31111622
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cicatrización de Heridas / Inhibidores de la Angiogénesis / Úlcera por Presión / Bevacizumab Límite: Aged / Humans / Male Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cicatrización de Heridas / Inhibidores de la Angiogénesis / Úlcera por Presión / Bevacizumab Límite: Aged / Humans / Male Idioma: En Año: 2019 Tipo del documento: Article